GMM Pfaudler Isn’t Revising Its FY21 Guidance Lower, Says Managing Director Tarak Patel
An employee holds Simvastatin 10mg tablets on the production line at the Hemofarm AG pharmaceutical plant, operated by Stada Arzniemittel AG, in Vrsac, Serbia (Photographer: Oliver Bunic/Bloomberg)

GMM Pfaudler Isn’t Revising Its FY21 Guidance Lower, Says Managing Director Tarak Patel

Indian drugmakers and chemical companies are finalising new orders as they have been relatively insulated from the national lockdown imposed in the aftermath of the novel coronavirus outbreak.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.